Pulsed Radiofrequency Ablation and Steroid Injections for the Treatment of Meralgia Paresthetica

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Meralgia Paresthetica
Interventions
PROCEDURE

Pulsed Radiofrequency Ablation

The area where the lateral femoral cutaneous nerve is seen with US will be anesthetized with 1 ml of 1% lidocaine and a 22 Gauge, 10 cm-5 mm RF cannula will be inserted. Sensory fibers will be stimulated with 0.3-0.5 V. Then, motor fibers will be stimulated up to 1.5 V. If no motor contraction is seen, LFCN will be ablated at 42 degrees Celsius for 240 seconds. The procedure will be completed with the injection of 2 ml of 2% lidocaine and 2 ml (8 mg) dexamethasone through the RF cannula.

DRUG

Steroid (dexamethasone) Injection

Where the lateral femoral cutaneous nerve is visible with US, 2 ml of 2% lidocaine and 2 ml (8 mg) dexamethasone will be injected.

Trial Locations (1)

06800

Ankara Bilkent City Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT06683924 - Pulsed Radiofrequency Ablation and Steroid Injections for the Treatment of Meralgia Paresthetica | Biotech Hunter | Biotech Hunter